GRAY MARY ANN
SEC CIK 1261974 · EDGAR
Most active insiders at KROS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneeberger Daniel | 10% | — | $95.66M |
| 2 | Pontifax (China) IV L.P. | 10% | — | $84.98M |
| 3 | Cho Esther | SVP, GC | — | $123.7K |
| 4 | Seehra Jasbir | CEO, Dir | — | $113.4K |
| 5 | Lerner Lorena Raquel | CSO | — | $100.0K |
| 6 | Regnante Keith | CFO | — | $77.5K |
| 7 | BIENAIME JEAN JACQUES | Dir | $75.8K | — |
| 8 | Knowles Julius | Dir | — | $28.2K |
| 9 | Farzan Nima | Dir | — | $28.2K |
| 10 | Seth Alpna | Dir | — | $28.1K |
| 16 | GRAY MARY ANN | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-05 16:15 | 2026-06-03 | KROS | Keros Therapeutics, Inc. | GRAY MARY ANN | Dir | A - Grant | $0.00 | +7,142 | 12.4K | +136% | $0 |
| D | 2025-06-06 | 2025-06-04 | KROS | Keros Therapeutics, Inc. | GRAY MARY ANN | Dir | A - Grant | $0.00 | +5,250 | 5,250 | New | $0 |
| D | 2022-03-08 | 2022-03-07 | SRPT | Sarepta Therapeutics, Inc. | GRAY MARY ANN | Dir | A - Grant | $0.00 | +2,953 | 12.4K | +31% | $0 |
| D | 2021-12-14 | 2021-12-10 | SRPT | Sarepta Therapeutics, Inc. | GRAY MARY ANN | Dir | M - OptEx | $0.00 | +967 | 9,403 | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations